Synthesis and anti-HIV activities of urea-PETT analogs belonging to a new class of potent non-nucleoside HIV-1 reverse transcriptase inhibitors

Bioorg Med Chem Lett. 1998 Jun 16;8(12):1511-6. doi: 10.1016/s0960-894x(98)00249-2.

Abstract

A series of potent specific HIV-1 RT inhibitory compounds is described. The compounds are urea analogs of PETT (PhenylEthylThiazoleThiourea) derivatives and the series includes derivatives with an ethyl linker (1-6) and conformationally restricted analogs (7-13). The antiviral activity is determined both at the RT level and in cell culture on both native and mutant forms of HIV-1. Many compounds display activity in the nM range against wt-RT.

MeSH terms

  • Anti-HIV Agents / chemical synthesis*
  • Anti-HIV Agents / metabolism
  • Anti-HIV Agents / pharmacology*
  • Blood Proteins / metabolism
  • Cell Line
  • HIV-1 / drug effects*
  • Humans
  • Microbial Sensitivity Tests
  • Protein Binding
  • Reverse Transcriptase Inhibitors / chemical synthesis*
  • Reverse Transcriptase Inhibitors / metabolism
  • Reverse Transcriptase Inhibitors / pharmacology*
  • Structure-Activity Relationship
  • Thiazoles / chemistry
  • Thiazoles / metabolism
  • Thiazoles / pharmacology*
  • Triazoles / chemistry
  • Triazoles / metabolism
  • Triazoles / pharmacology*

Substances

  • Anti-HIV Agents
  • Blood Proteins
  • Reverse Transcriptase Inhibitors
  • Thiazoles
  • Triazoles
  • 2-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole